STRS Ohio’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1M | Buy |
55,700
+53,335
| +2,255% | +$1.01M | ﹤0.01% | 737 |
|
|
2026
Q1 | $51.5K | Buy |
2,365
+144
| +6% | +$2.79K | ﹤0.01% | 1927 |
|
|
2025
Q4 | $47.8K | Buy |
2,221
+4
| +0.2% | +$84 | ﹤0.01% | 1991 |
|
|
2025
Q3 | $42.7K | Hold |
2,217
| – | – | ﹤0.01% | 2033 |
|
|
2025
Q2 | $37.9K | Buy |
+2,217
| New | +$94.6K | ﹤0.01% | 2068 |
|
|
2024
Q4 | – | Sell |
-8,715
| Closed | -$1.09M | – | 2039 |
|
|
2024
Q3 | $1.09M | Buy |
8,715
+3,030
| +53% | +$419K | ﹤0.01% | 879 |
|
|
2024
Q2 | $898K | Sell |
5,685
-10,315
| -64% | -$1.33M | ﹤0.01% | 914 |
|
|
2024
Q1 | $2.07M | Sell |
16,000
-4,000
| -20% | -$490K | 0.01% | 620 |
|
|
2023
Q4 | $1.93M | Hold |
20,000
| – | – | 0.01% | 620 |
|
|
2023
Q3 | $2.42M | Sell |
20,000
-6,665
| -25% | -$753K | 0.01% | 550 |
|
|
2023
Q2 | $3.05M | Buy |
26,665
+19,846
| +291% | +$2.56M | 0.01% | 522 |
|
|
2023
Q1 | $939K | Sell |
6,819
-260
| -4% | -$33.7K | ﹤0.01% | 968 |
|
|
2022
Q4 | $917K | Buy |
7,079
+477
| +7% | +$55.3K | ﹤0.01% | 970 |
|
|
2022
Q3 | $729K | Buy |
+6,602
| New | +$665K | ﹤0.01% | 1093 |
|
|
2021
Q2 | – | Sell |
-837
| Closed | -$62K | – | 2418 |
|
|
2021
Q1 | $62K | Hold |
837
| – | – | ﹤0.01% | 2010 |
|
|
2020
Q4 | $142K | Sell |
837
-4,641
| -85% | -$688K | ﹤0.01% | 1818 |
|
|
2020
Q3 | $769K | Buy |
+5,478
| New | +$833K | ﹤0.01% | 1080 |
|
|
2019
Q2 | – | Sell |
-1,375
| Closed | -$167K | – | 2201 |
|
|
2019
Q1 | $163K | Sell |
1,375
-219
| -14% | -$28.2K | ﹤0.01% | 1718 |
|
|
2018
Q4 | $173K | Buy |
1,594
+4
| +0.3% | +$500 | ﹤0.01% | 1665 |
|
|
2018
Q3 | $256K | Sell |
1,590
-15
| -0.9% | -$2.05K | ﹤0.01% | 1658 |
|
|
2018
Q2 | $212K | Sell |
1,605
-8,095
| -83% | -$763K | ﹤0.01% | 1726 |
|
|
2018
Q1 | $718K | Buy |
9,700
+3,500
| +56% | +$233K | ﹤0.01% | 1106 |
|
|
2017
Q4 | $344K | Buy |
6,200
+1,600
| +35% | +$84.8K | ﹤0.01% | 1405 |
|
|
2017
Q3 | $208K | Buy |
+4,600
| New | +$184K | ﹤0.01% | 1533 |
|
|
2016
Q4 | – | Sell |
-4,200
| Closed | -$257K | – | 1987 |
|
|
2016
Q3 | $257K | Buy |
+4,200
| New | +$127K | ﹤0.01% | 1497 |
|
|
2013
Q4 | – | Sell |
-5,000
| Closed | -$236K | – | 1809 |
|
|
2013
Q3 | $236K | Sell |
5,000
-400
| -7% | -$15.4K | ﹤0.01% | 1442 |
|
|
2013
Q2 | $205K | Buy |
+5,400
| New | +$193K | ﹤0.01% | 1495 |
|
Other funds holding SRPT
EAM
STRS Ohio's SRPT Position: Q2 2026 in Review
STRS Ohio increased its Sarepta Therapeutics (SRPT) stake by 2,255% in Q2 2026, buying an estimated $1.01M and bringing the position to 55,700 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #737.
STRS Ohio first reported a position in SRPT in Q2 2013 and has held it in 27 quarters since. The position peaked at $3.05M in Q2 2023. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- STRS Ohio held 55,700 shares of Sarepta Therapeutics worth $1M as of Q2 2026.
- STRS Ohio bought 53,335 Sarepta Therapeutics shares in Q2 2026, an estimated $1.01M.
- Sarepta Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #737 holding.
- STRS Ohio first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 27 quarters since.
- STRS Ohio's Sarepta Therapeutics position peaked at $3.05M in Q2 2023.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.